2022
DOI: 10.1016/j.molstruc.2022.132474
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization and relaxivity validations of Gd(III) complex of DOTA tetrahydrazide as MRI contrast agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 36 publications
1
2
0
Order By: Relevance
“…1 H NMR (400 MHz, CDCl 3 ): δ 3.92 (s, 2H), 1.49 (s, 9H). The obtained 1 H NMR spectrum was consistent with the report in the precedent literature [40]. HRESI-MS: m/z calculated for [M+ Na] + : 275.0; Found 275.0.…”
Section: Synthesis Of N-boc-2-bromoacetohydrazidesupporting
confidence: 89%
See 1 more Smart Citation
“…1 H NMR (400 MHz, CDCl 3 ): δ 3.92 (s, 2H), 1.49 (s, 9H). The obtained 1 H NMR spectrum was consistent with the report in the precedent literature [40]. HRESI-MS: m/z calculated for [M+ Na] + : 275.0; Found 275.0.…”
Section: Synthesis Of N-boc-2-bromoacetohydrazidesupporting
confidence: 89%
“…N-boc-2-bromoacetohydrazide was synthesized according to the method in the previous literature [40], as shown in Scheme 1A. To a solution of t-butyl carbazate (5 g, 37.8 mmol, 1.0 equiv.)…”
Section: Synthesis Of N-boc-2-bromoacetohydrazidementioning
confidence: 99%
“…Wang et al showed that the luminous efficiency of CaF 2 : Nd co-doped Ce 3+ was 10.4 times higher than that of CaF 2 : Nd [47]. On the other hand, the seven unpaired electrons of Gd(III) can increase the proton relaxation rate, making Gd 3+ a common contrast agent in MR bioimaging [48,49]. Therefore, we choose Ce 3+ , Gd 3+ and Nd 3+ co-doping CaF 2 as the Pharmaceutics 2022, 14, 2796 3 of 18 material in our strategy to construct an imaging mode combining NIR-II imaging with complementary MRI and PAI.…”
Section: Introductionmentioning
confidence: 99%